Related Experiment Videos
Increased cellular expression of the caspase inhibitor FLIP in intrathecal lymphocytes from patients with multiple
1Department of Neuroimmunology, Guy's, King's and St. Thomas' School of Medicine, Hodgkin Building, Guy's Hospital, SE1 9RT, London, UK. m.sharief@umds.ac.uk
Abstract:
Failure of Fas-mediated apoptosis of potentially pathogenic, autoreactive T lymphocytes may be involved in the pathogenesis of multiple sclerosis. The intracellular protein FLIP, a naturally occurring caspase-antagonist, is a potent inhibitor of the Fas signalling pathway that may block Fas-mediated apoptosis of activated lymphocytes. This study reports specific overexpression of both long and short forms of FLIP in intrathecal lymphocytes from patients with multiple sclerosis. The overexpression of FLIP is independent of cellular expressions of Fas receptor or the anti-apoptotic protein Bcl-2. These results provide a better understanding of some of the intrinsic immunoregulatory mechanisms that are involved in multiple sclerosis.
Insights
In multiple sclerosis, T lymphocytes resist apoptosis due to increased FLIP protein, a caspase-antagonist. This FLIP overexpression, observed in spinal fluid cells, hinders programmed cell death, potentially contributing to disease pathogenesis.
Area of Science:
- Immunology
- Neuroscience
- Cell Biology
Background:
- Multiple sclerosis pathogenesis may involve the failure of T lymphocytes to undergo apoptosis.
- The Fas signalling pathway is crucial for inducing apoptosis in activated lymphocytes.
- FLIP (FLICE-inhibitory protein) is an intracellular protein that antagonizes caspases and inhibits Fas-mediated apoptosis.
Purpose of the Study:
- To investigate the expression levels of FLIP in lymphocytes from patients with multiple sclerosis.
- To determine if FLIP overexpression correlates with Fas receptor or Bcl-2 expression in these patients.
Main Methods:
- Analysis of FLIP (long and short forms) expression in intrathecal lymphocytes.
- Assessment of Fas receptor and Bcl-2 expression in the same cell populations.
Main Results:
- Specific overexpression of both long and short forms of FLIP was detected in intrathecal lymphocytes from multiple sclerosis patients.
- FLIP overexpression was independent of cellular expression levels of the Fas receptor.
- FLIP overexpression was also independent of the expression of the anti-apoptotic protein Bcl-2.
Conclusions:
- Overexpression of FLIP in intrathecal lymphocytes is a specific finding in multiple sclerosis.
- This FLIP overexpression may represent an intrinsic immunoregulatory mechanism contributing to the pathogenesis of multiple sclerosis by inhibiting T lymphocyte apoptosis.
- The findings offer new insights into the molecular mechanisms underlying immune dysregulation in multiple sclerosis.